Clinical Research Directory
Browse clinical research sites, groups, and studies.
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Sponsor: Carevive Systems, Inc.
Summary
The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.
Official title: Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia (AML) Using Remote Symptom Monitoring
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
25
Start Date
2023-07-19
Completion Date
2026-12-31
Last Updated
2026-02-23
Healthy Volunteers
No
Interventions
Web based survey
online weekly survey
Locations (7)
Yale Cancer Center
New Haven, Connecticut, United States
Northshore University Health System
Evanston, Illinois, United States
Univeristy of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Duke
Durham, North Carolina, United States
Cleveland Clinic Mercy Hospital
Canton, Ohio, United States
University Hospitals Seidman Cancer Center
Cleveland, Ohio, United States
Tri-County Hematology & Oncology Associates, Inc.
Massillon, Ohio, United States